YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQQC5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,886
Award facts
- Contract value 100% obligated
- $18,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,886.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on January 20, 2026, with an ultimate completion date of February 10, 2026, carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to provide efficient pharmaceutical supply chain management for Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated consistent performance as a critical pharmaceutical supplier within the federal military medical system, with the parent IDC valued at $499,999,999 and extending through December 31, 2036. The company's product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill diverse medical supply requirements across military healthcare operations globally. As a single-award prime vendor contractor under PPV-G GEN V, DMS Pharmaceutical Group operates without identified subcontractors and has received numerous delivery orders from the Defense Logistics Agency's Medical Supply Chain division, reflecting its capability to support recurring and specialized pharmaceutical needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FQQC5?
SPE2DR26FQQC5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQQC5 worth?
The government has obligated $18,886 on SPE2DR26FQQC5.
Is contract SPE2DR26FQQC5 an order under another contract?
Yes. SPE2DR26FQQC5 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQQC5 competed?
The extent of competition for SPE2DR26FQQC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award